Jens Frederik Dahlerup
Aarhus University Hospital
Vitamin D and neurologyInternal medicineEndocrinologySurgeryPediatricsCohort studyImmunologyInfliximabInflammatory bowel diseaseCytokineDiseaseCrohn's diseaseUlcerative colitisPopulationINCEPTION COHORTIncidence (epidemiology)MedicineCohortBiologyImmune systemGastroenterology
195Publications
36H-index
3,923Citations
Publications 195
Newest
#1Palle Bager (Aarhus University Hospital)H-Index: 16
#2Christian Lodberg Hvas (Aarhus University Hospital)H-Index: 21
Last. Jens Frederik Dahlerup (Aarhus University Hospital)H-Index: 36
view all 4 authors...
Fatigue is common in inflammatory bowel disease (IBD). In a RCT we demonstrated reductions in fatigue after 4 weeks' treatment with high-dose oral thiamine. We aimed to investigate whether 300 mg t...
Source
#1Frederik Cold (Copenhagen University Hospital)H-Index: 5
#2Simon Mark Dahl Baunwall (Aarhus University Hospital)H-Index: 2
Last. Lars Hestbjerg Hansen (UCPH: University of Copenhagen)H-Index: 57
view all 6 authors...
Background:Faecal microbiota transplantation (FMT) is an effective treatment of recurrent Clostridioides difficile infection (rCDI) and is being applied experimentally in other diseases. Encapsulat...
Source
#1Simon Mark Dahl Baunwall (Aarhus University Hospital)H-Index: 2
#2Elisabeth M. Terveer (LUMC: Leiden University Medical Center)H-Index: 9
Last. Patrizia Kump (Medical University of Graz)H-Index: 13
view all 40 authors...
Abstract null null Background null Faecal microbiota transplantation (FMT) is an emerging treatment modality, but its current clinical use and organisation are unknown. We aimed to describe the clinical use, conduct, and potential for FMT in Europe. null null null Methods null We invited all hospital-based FMT centres within the European Council member states to answer a web-based questionnaire covering their clinical activities, organisation, and regulation of FMT in 2019. Responders were ident...
1 CitationsSource
#1Simon Mark Dahl Baunwall (Aarhus University Hospital)H-Index: 2
#2Jens Frederik Dahlerup (Aarhus University Hospital)H-Index: 36
Last. Anne A RodeH-Index: 2
view all 12 authors...
Aim: This Danish national guideline describes the treatment of adult patients with Clostridioides (formerly Clostridium) difficile (CD) infection and the use of faecal microbiota transplantation (FMT). It suggests minimum standard for implementing an FMT service.Method: Four scientific societies appointed members for a working group which conducted a systematic literature review and agreed on the text and recommendations. All clinical recommendations were evalluated for evidence level and grade ...
Source
#1Pernille Glahn Wernlund (AU: Aarhus University)H-Index: 2
#2Christian Lodberg Hvas (Aarhus University Hospital)H-Index: 21
Last. Jørgen Agnholt (Aarhus University Hospital)H-Index: 26
view all 7 authors...
Casein glycomacropeptide (CGMP) is a bioactive milk-derived peptide with potential anti-inflammatory effects. Animal studies suggest that CGMP may work by altering gut microbiota composition and enhancing butyrate production. Its effects on intestinal homoeostasis, microbiota and metabolites in humans are unknown. The aim of the present study was to assess both the intestinal and systemic immunomodulatory effects of orally ingested CGMP. We hypothesised that daily oral CGMP intake would reduce h...
2 CitationsSource
Source
#1Sine BuhlH-Index: 5
#2Casper SteenholdtH-Index: 22
Last. Mark A. AinsworthH-Index: 29
view all 27 authors...
Source
#1Palle Bager (Aarhus University Hospital)H-Index: 16
#2Christian Lodberg Hvas (Aarhus University Hospital)H-Index: 21
Last. Jens Frederik Dahlerup (Aarhus University Hospital)H-Index: 36
view all 4 authors...
1 CitationsSource
#1Mia BendixH-Index: 7
#2Anders DigeH-Index: 18
Last. Jørgen AgnholtH-Index: 26
view all 7 authors...
Background: Seven weeks of high-dose vitamin D treatment decreases intestinal IL17A and IFN-γ mRNA expression in active Crohn’s disease (CD). In this follow-up study, we investigated whether seven-week vitamin D treatment affected the infliximab response in the following 45 weeks compared to placebo. Methods: CD patients (n = 40) were initially randomised into four groups: infliximab + vitamin-D; infliximab + placebo-vitamin-D; placebo-infliximab + vitamin-D; and placebo-infliximab + placebo-vit...
1 CitationsSource
#1Palle Bager (Aarhus University Hospital)H-Index: 16
#2Christian Lodberg Hvas (Aarhus University Hospital)H-Index: 21
Last. Jens Frederik Dahlerup (Aarhus University Hospital)H-Index: 36
view all 4 authors...
Source